2024 Midwest Radiation Oncology Symposium (Attendee Information)
Welcome! Thank you for joining us.
This symposium aims to bring together the brilliant minds of physicians and physicists, fostering an interdisciplinary dialogue that explores the immense potential of AI in revolutionizing radiation oncology.
Our primary objectives are to delve into the latest advancements, share groundbreaking research, and discuss collaborative strategies for integrating AI seamlessly into clinical practices.
This symposium is a unique opportunity to explore the intersection of medicine and technology.
Symposium Dates
|
|
Friday-Saturday, Aug. 23-24 Friday: 7:00 a.m. – 4:20 p.m. US CDT |
Attendance Options
 |
In-Person Complimentary parking for campus visitors is available in Lot 50 — top level only (45th and Emile). |
 |
Live Stream Via Zoom – Check your email for instructions on how to join the live stream. |
Symposium Objectives
At the conclusion of this activity, the participants should be better able to:
- Explore the transformative role of technology in modern oncology, encompassing Artificial Intelligence integration in radiotherapy practices, advancements in medical image analysis, and its impact on personalized treatment approaches.
- Investigate innovative radiation techniques such as proton FLASH and stereotactic body radiotherapy (SBRT), focusing on mechanisms of action and their potential applications across different cancer types.
- Examine strategies for effective patient communication and education, including eLearning, simulation-based training, and the role of global health rotations in residency programs for fostering cultural competency and enhancing patient care.
- Evaluate the evolving landscape of cancer diagnosis, with a spotlight on the application of AI in brain tumor detection and characterization.
- Discuss contemporary approaches to the management of various malignancies, including early-stage non-small cell lung cancer, renal masses, and prostate cancer risk stratification through radiomics.
- Explore the multidisciplinary nature of cancer treatment, with insights into the roles and responsibilities of healthcare professionals in delivering comprehensive care at community cancer centers.
- Identify current and emerging surgical and radiotherapy strategies for soft tissue sarcoma management.
- Review the latest advancements in the treatment of hepatocellular carcinoma, including Y90 radioembolization, SBRT, and immunotherapy.
Target Audience
This accredited continuing education activity is designed for medical physicists, radiation therapists, dosimetrists, nurses, physicians, fellows, residents, and students.
Symposium Agenda
Download symposium agenda
In support of improving patient care, University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
The University of Nebraska Medical Center designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
The University of Nebraska Medical Center designates this activity for 13.5 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
Medical Physicists
This activity has applied to CAMPEP and has been approved for 13.66 MPCEC hours.
Radiation Therapists
This activity has been approved by the American Society of Radiologic Technologists (ASRT) for 16.25 Category A continuing education credits.
Dosimetrists
This activity is approved by the Medical Dosimetrist Certification Board (MDCB) for 13.00 MDCB continuing education credits
Read the UNMC CCE Disclosure Declaration Policy
Disclosures
The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles.
FACULTY
The following have disclosed relevant financial relationships:
- Clifton David Fuller, MD, PhD
Advisory Service/Honoraria/Travel: Varian Medical Systems, Inc. (A Siemens Healthineers Company)
Grants/Honoraria/Travel: Elekta
Honoraria/Travel: Koninklijke Philips N.V.
Patents/Royalties: Kallisio, Inc. - Megan Hyun, PhD, DABR
Speaker's Bureau: Varian Medical Systems, Inc. (A Siemens Healthineers Company) - Harshraj Leuva, MBBS
Advisory Board: Astellas Pharma Inc., Seagen Inc. - Joseph McBride, MD
Consultant: Integer Holdings Corporation
- Sean McGarry, MD
Medical Board of Trustees: Musculoskeletal Transplant Foundation (MTF) - Jeffery Ryckman, MD
Advisory Board: NewLeaf.ai, Inc. - Nicole Shonka, MD
Consultant: GT Medical Technologies, Inc.
- Chi (Kevin) Zhang, MD, PhD*
Grant: AstraZeneca, BioMimetix Pharma
Co-founder: ZCure LLC - Dandan Zheng, PhD, DABR
Research Agreement: Varian Medical Systems, Inc. (A Siemens Healthineers Company)
The following faculty members have nothing to disclose:
- Omar K.M. Abughanimeh, MBBS
- Michele Aizenberg, MD, FAANS, FACS
- Hana Baroudi, MS
- David Berkheim, MD
- Lisa Chaiken, MD
- Serdar Charyyev, PhD
- Jie Chen, MD, PhD
- Yabo Fu, PhD
- Kyle J. Gallagher, PhD, DABR
- Hao Gao, PhD
- Linda M. Huynh, PhD, MSc
- Qateeb Khan, MD
- Mridula Krishnan, MBBS
- Chi Lin, MD, PhD*
- Ruirui Liu, PhD, CHP
- Sara Abou Naej, MS
- Kyuhak Oh, PhD
- Jared P. Schober, MD
- Diane Schott, PhD, DABR
- Andrew Wahl, MD
- Shuo Wang, PhD
- Xiaofeng Yang, PhD, DABR
- Xiandong Zhao, PhD
- Weining (Ken) Zhen, MD, FACR, FASTRO
- Sumin Zhou, PhD
PLANNING COMMITTEE
The following planning committee members have nothing to disclose:
- Michael Baine, MD, PhD
- Dinah Clark
- Valeta Creason-Wahl, HMCC
- Charles Enke, MD, FACR, FASTRO
- Tori Greenlee
- Julie Huglin
- Heidi Keeler, PhD, MSN/MBA, RN
- Yu Lei, PhD
- Renee Paulin, MSN, RN, CWOCN
- Brenda Ram, CMP, CHCP
- Hongmei Ren, BSN, RN
- Ann L. Yager, MHA, BS, RT, (R) (T), CT
*Faculty and planning committee member
Requirements for Successful Completion
In order to receive continuing education credits, you must:
- Check in and attend the live activity.
- In-person: Check in at the registration desk.
- Live stream: Type in your first and last name in the Zoom chat.
- Complete the online evaluation via the UNMC MyCCE portal.
- On your dashboard, click Evaluate an Activity.
- Live Stream attendees, enter Activity Code:
62023 – Friday, August 23 only
62025 – Saturday, August 24 only
62027 – Full Symposium - In Person attendees, enter Activity Code:
62022 – Friday, August 23 only
62024 – Saturday, August 24 only
62026 – Full Symposium
You have until Sept. 13, 2024, to claim credit for this activity. You will need to complete the evaluation and attest to the time you spent participating in the activity. Your certificate will be saved in your UNMC MyCCE account under Certificates & Transcripts.
Need help managing your MyCCE account? Find answers to commonly asked questions about signing in to the portal, completing the online evaluation, retrieving your certificate, and more. Go to Manage MyCCE Account
Symposium Director
Chi Lin, MD, PhD
Professor and Vice Chair of Research, Department of Radiation Oncology, UNMC
Questions?
Brenda Ram, CMP, CHCP
Director, Educational Programs
UNMC Center for Continuing Education
